HLS in Canada is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties.
|Absorica||Acne||U.S.||Acquired 2016||Marketed by a third party|
|Vascepa||CV risk reduction||Canada||Approved 2019||Marketed|
|CSAN Pronto||WBC Point-of-Care Diagnostic||Canada||Approved 2019||Marketed|
|Trinomia||CV risk reduction||Canada||In-licensed 2017||Submission under review|
|Perseris||Schizophrenia||Canada||In-licensed 2019||Submission under review|
For Canadian Residents, click here for commercial product information.
For U.S. Residents, click on the American flag above for more commercial product information.
Returned Goods →
Brand names you know. Safe and effective results you trust.